Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study
Plasma p-tau181 is not only a good diagnostic marker for AD pathology, but it also plays a role as a predictor of both conversion to AD dementia and of worsening of cognitive performance since the earliest phase of AD.
Authors
- Laura Falsini
- Giulia Giacomucci (ORCID: https://orcid.org/0000-0002-8711-331X)
- Carmen Morinelli
- Sonia Padiglioni
- Benedetta Nacmias (ORCID: https://orcid.org/0000-0001-9338-9040)
- Valentina Moschini
- Silvia Bagnoli (ORCID: https://orcid.org/0000-0002-4373-6611)
- Valentina Berti (ORCID: https://orcid.org/0000-0001-9947-6559)
- Assunta Ingannato (ORCID: https://orcid.org/0000-0003-4955-0321)
- Valentina Bessi
- Chiara Crucitti
- Sandro Sorbi
- Elisa Marcantelli
Institutions
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Don Carlo Gnocchi Foundation (IT)
- Agenzia Regionale di Sanità della Toscana (IT)
- University of Florence (IT)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.1002/acn3.70190
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- European Commission
- Regione Toscana